Weight management

Suggested

8 studies · 1 recommendation

Last updated: February 25, 2026

Weight management – Colorectal Cancer
Suggested8 studies

Maintaining healthy body weight reduces colorectal cancer risk and improves post-diagnosis survival

Eight studies—including a meta-analysis of 43,419 older adults, an IARC consensus statement, four systematic reviews, and two cohort studies—consistently link excess body fatness to elevated colorectal cancer risk. The IARC working group reported relative risks of 1.5–1.8 for obesity versus normal BMI (overall RR 1.3, 95% CI 1.3–1.4) with a significant dose-response relationship confirmed by Mendelian randomization. Per standard deviation increase, waist circumference raised colorectal cancer risk by 21% (HR 1.21). Obesity at age 21 persisting to screening doubled the odds of advanced neoplasia (OR 1.87, 95% CI 1.08–3.23). Critically, high physical activity does not offset obesity-related risk, making weight control independently necessary. Post-diagnosis, BMI of 38 kg/m² was associated with 23–26% higher mortality and 24% greater recurrence compared to the optimal range. Childhood obesity also showed a positive link to adult colorectal neoplasia across 30 studies.

Evidence

Authors: Aune, Dagfinn, Balducci, Katia, Baskin, Monica L., Becerra‐Tomás, Nerea, Bours, Martijn, Cariolou, Margarita, Chowdhury, Rajiv, Copson, Ellen, Demark‐Wahnefried, Wendy, Dossus, Laure, Greenwood, Darren C., Hill, Lynette, Hudson, Melissa M., Kiss, Sonia, Krebs, John, Lewis, Sarah J., Markozannes, Georgios, May, Anne M., Odedina, Folakemi T., Renehan, Andrew G., Skinner, Roderick, Steindorf, Karen, Tjønneland, Anne, Velikova, Galina, Vieira, Rita

Published: May 1, 2024

A systematic review and meta-analysis of 124 observational studies (85 publications) found a non-linear reverse J-shaped association between post-diagnosis BMI and colorectal cancer outcomes, with the nadir at BMI 28 kg/m². Compared to the nadir, BMI of 38 kg/m² was associated with 23% higher all-cause mortality, 26% higher colorectal cancer-specific mortality, and 24% higher cancer recurrence or worse disease-free survival. The CUP Global Expert Committee graded all associations as limited due to potential reverse causation, confounding, and selection bias.

Authors: Aune D, Balducci K, Baskin ML, Becerra-Tomas N, Bours M, Cariolou M, Chan DSM, Chowdhury R, Copson E, Cross AJ, Demark-Wahnefried W, Dossus L, Greenwood DC, Hill L, Hudson MM, Kiss S, Krebs J, Lewis SJ, Markozannes G, May AM, Odedina FT, Renehan AG, Seidell J, Skinner R, Steindorf K, Tjonneland A, Tsilidis KK, Velikova G, Vieira R, Weijenberg MP

Published: January 1, 2024

Systematic review and meta-analysis of 124 observational studies (85 publications) with non-linear random-effects meta-analysis. A reverse J-shaped association between post-diagnosis BMI and colorectal cancer outcomes was identified, with the nadir at BMI 28 kg/m². Relative to this nadir, BMI of 18 kg/m² was associated with 60% higher all-cause mortality, 95% higher colorectal cancer-specific mortality, and 37% higher cancer recurrence risk. BMI of 38 kg/m² was associated with 23% higher all-cause mortality, 26% higher cancer-specific mortality, and 24% higher recurrence risk. The expert panel graded all associations as limited due to potential reverse causation, confounding, and selection bias.

Authors: Nunez Miranda, Carols Andres

Published: September 18, 2019

A systematic review evaluating the independent and interactive effects of body mass and physical activity on cancer risk across multiple epidemiological studies found a consistent positive association between obesity and colorectal cancer incidence, with colon cancer showing the strongest link among both sexes. When the interaction term between body fatness and physical activity was formally assessed, no statistically significant interaction was detected for colorectal cancer outcomes, indicating that the 'fat but fit' hypothesis does not apply. Obesity-related colorectal cancer risks were not attenuated or eliminated by high levels of physical activity or cardiorespiratory fitness, confirming that weight control is independently necessary for risk reduction.

Authors: Champion, Victoria L., Gathirua-Mwangi, Wambui G., Imperiale, Thomas F., Monahan, Patrick, Song, Yiqing, Stump, Timothy E., Zollinger, Terrell W.

Published: October 5, 2017

Among 4,500 adults aged 50–80 with no prior neoplasia, those who were obese (BMI ≥ 30) at age 21 and remained obese at screening had an OR of 1.87 (95% CI 1.08–3.23) for advanced colorectal neoplasia compared to those who maintained a healthy BMI throughout adulthood. Notably, maintaining an overweight BMI or simply increasing BMI without reaching obesity was not significantly associated with advanced neoplasia risk. BMI and waist circumference at age 21 and at screening were self-reported and measured respectively, with changes defined using universal risk cutoffs and known CRC risk factors controlled in logistic regression models.

Authors: Arnold, Melina, Bamia, Christina, Benetou, Vassiliki, Boffetta, Paolo, Brenner, Hermann, Bueno-de-Mesquita, H B As, Freisling, Heinz, Huerta, José María, Jenab, Mazda, Kampman, Ellen, Kee, Frank, Leitzmann, Michael, O'Doherty, Mark George, Ordóñez-Mena, José Manuel, Romieu, Isabelle, Soerjomataram, Isabelle, Tjønneland, Anne, Trichopoulou, Antonia, Tsilidis, Konstantinos K, Wilsgaard, Tom

Published: January 1, 2017

Meta-analysis of 7 prospective cohorts (18,668 men, 24,751 women; mean age 62-63 years; median follow-up 12 years) with 1,656 first-incident obesity-related cancers. Per standard deviation increment, colorectal cancer risk increased by 16% for BMI (HR 1.16), 21% for waist circumference (HR 1.21), 15% for hip circumference (HR 1.15), and 20% for waist-to-hip ratio (HR 1.20). Waist circumference demonstrated the strongest individual association with colorectal cancer among all four anthropometric indicators assessed.

Authors: Anderson, Annie S., Baker, Jennifer L., Bianchini, Franca, Breda, João, Byers, Tim, Clearly, Margot P., Colditz, Graham, Di Cesare, Mariachiara, Gapstur, Susan M., Grosse, Yann, Gunter, Marc, Herbert, Ronald A., Hursting, Stephen D., Kaaks, Rudolf, Lauby-Secretan, Béatrice, Leitzmann, Michael, Ligibel, Jennifer, Loomis, Dana, Renehan, Andrew, Romieu, Isabelle, Scoccianti, Chiara, Shimokawa, Isao, Straif, Kurt, Thompson, Henry J., Ulrich, Cornelia M., Wade, Katlin, Weiderpass, Elisabete

Published: August 24, 2016

The IARC working group reaffirmed sufficient evidence that absence of excess body fatness lowers colorectal cancer risk, originally established in 2002. Meta-analyses and pooled analyses showed relative risks of 1.2 to 1.5 for overweight and 1.5 to 1.8 for obesity, with a reported overall relative risk of 1.3 (95% CI, 1.3–1.4) for the highest BMI category versus normal BMI. A significant positive dose-response relationship was observed. Results based on waist circumference were generally consistent with those reported for BMI. When studies from different geographic regions were available, results were consistent across regions. Stratification by sex generally showed similarly increased risks among men and women. Mendelian randomization studies on colorectal cancer confirmed agreement with observational cohort and case-control study findings, strengthening the causal interpretation.

Authors: Schumacher, Makaila A.

Published: March 30, 2016

A systematic review screened 658 articles from PubMed and CINAHL databases, selecting 30 peer-reviewed studies published between 2004 and 2014 for final analysis. Strong evidence supported a positive association between childhood and adolescent obesity and colorectal adenoma in women and colon cancer in males. Limited evidence of a positive association was also identified for colorectal cancer in both males and females across the pooled studies. The review characterized the childhood obesity–colorectal cancer link as among the more consistent findings across the 30 included studies.

Authors: A Tavani, Burger HG, C La Vecchia, Di Domenico M, E Negri, English MA, Fernandez E, Franceschi S, Franceschi S, H&eacute, Hahnn RA, Jacobs EJ, Kampman E, Kampman E, Kuiper GGJM, La Vecchia C, Martinez ME, Negri E, Negri E, R Talamini, Rannevik G, S Franceschi, S Gallus, Talamini R, Troisi R

Published: January 1, 2000

A cohort study found that post-menopausal women who never used hormone replacement therapy had a higher risk of colon cancer (but not rectal cancer) compared to premenopausal women of the same age, socio-cultural class, and dietary habits. This elevated risk persisted for approximately 10 years after menopause and was restricted to lean women — a subgroup characterized by lower levels of oestradiol following cessation of ovarian function. The association between leanness and increased colon cancer risk suggests that endogenous oestrogen levels play a protective role, and that body composition mediates this relationship in the post-menopausal period.